Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GNMSF | AMGN | GILD | VRTX | BIIB |
| Company | Genmab A/S | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 287.0600 | 264.63 | 66.25 | 394.72 | 190.72 |
| High | 288.3000 | 269.17 | 66.72 | 396.98 | 194.07 |
| Low | 283.3000 | 260.68 | 66.16 | 391.25 | 189.44 |
| Last | 284.5500 | 268.91 | 66.74 | 394.22 | 193.68 |
| Change | -5.8300 | +6.16 | +0.58 | +0.74 | +3.16 |
| % Change | -2.01% | +2.34% | +0.88% | +0.19% | +1.66% |
| Volume | 238 | 1,829,211 | 4,860,980 | 794,995 | 931,811 |
| 20-Day Average Volume | 397 | 2,159,968 | 6,153,123 | 903,031 | 1,103,680 |
| Previous Close | 290.3800 | 262.75 | 66.16 | 393.48 | 190.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 294.5003 | 272.56 | 69.88 | 405.45 | 204.97 |
| 20-Day Raw Stochastic | 18.97% | 29.01% | 6.65% | 6.52% | 11.57% |
| 20-Day Relative Strength | 45.63% | 43.79% | 29.48% | 36.60% | 30.72% |
| Weighted Alpha | -30.27 | +7.59 | -24.84 | +15.42 | -37.56 |
| Today's Opinion | 88% Sell | 56% Sell | 100% Sell | 8% Sell | 100% Sell |
| Previous Opinion | 88% Sell | 56% Sell | 100% Sell | 8% Buy | 100% Sell |
| Last Month's Opinion | 56% Sell | 8% Sell | 72% Sell | 40% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.26% since 04/12/24 | +0.56% since 04/12/24 | -2.41% since 04/12/24 | -0.90% since 04/12/24 | -2.55% since 04/12/24 |
| Low | 278.4600 on 04/15/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 295.9400 on 04/16/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 402.49 on 04/15/24 | 199.53 on 04/15/24 |
| 1-Month | |||||
| %Chg | -3.54% since 03/19/24 | -1.09% since 03/19/24 | -9.51% since 03/19/24 | -5.35% since 03/19/24 | -11.66% since 03/19/24 |
| Low | 278.4600 on 04/15/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 310.5600 on 03/27/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 | 221.74 on 03/21/24 |
| 3-Month | |||||
| %Chg | -0.78% since 01/19/24 | -12.68% since 01/19/24 | -23.90% since 01/19/24 | -9.66% since 01/19/24 | -22.74% since 01/19/24 |
| Low | 262.0000 on 02/13/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 323.0180 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 | 252.17 on 01/22/24 |
| 6-Month | |||||
| %Chg | -0.42% since 10/19/23 | -4.22% since 10/19/23 | -15.31% since 10/19/23 | +7.73% since 10/19/23 | -24.94% since 10/19/23 |
| Low | 262.0000 on 02/13/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 | 189.44 on 04/19/24 |
| High | 334.3280 on 01/08/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,982,142 | 140,812,720 | 82,374,304 | 101,698,464 | 27,694,178 |
| Shares Outstanding, K | 65,370 | 535,919 | 1,245,077 | 258,459 | 145,361 |
| Annual Sales | 2,392,030,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | 631,910,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 674,810,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 2,386,300,000 |
| Last Quarter Net Income | 90,250,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 249,700,000 |
| 60-Month Beta | 1.01 | 0.58 | 0.19 | 0.35 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | 3.63 on 02/14/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 2.95 on 02/13/24 |
| Latest Earnings Date | 05/08/24 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 23.71 | 14.16 | 9.96 | 29.25 | 13.05 |